Biovana is a Nigerian-based startup specializing in the harmonization and certification of health data from Africa for use in global pharmaceutical and AI research. Co-founded by Estelle Dogbo and Dr. Jumi Popoola, Biovana leverages cutting-edge technology to clean and standardize vast health datasets from across Africa, aiming to unlock insights for industries ranging from biotechnology to artificial intelligence. The company has not currently raised any major funding rounds publicly but was recently a part of Madica's funding initiative, which supports underrepresented founders in Africa.
| Attribute | Information |
|---|---|
| Founding Date | Not publicly disclosed |
| Headquarters | Nigeria |
| Founders | Estelle Dogbo, Dr. Jumi Popoola |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Madica |
| Industry | Health Data and Biobank Infrastructure |
| Number of Employees | Not publicly disclosed |
Biovana was founded with the aim of addressing the gap in accessible and standardized health data across Africa. Estelle Dogbo, with a background in cell biology, alongside Dr. Jumi Popoola, sought to build a company that could unlock the potential of African health data for global research purposes. Their collaboration began as they saw the vast amounts of fragmented and underutilized data across African nations. Understanding the potential to influence biotechnological and pharmaceutical research globally, the founders embarked on creating a data platform to address these challenges.
Biovana operates a platform that streamlines the preparation of health data, making it usable for international research entities. The company strives to integrate ethical considerations with technological advancements to ensure data privacy and compliance with global standards. Its business model focuses on collaborating with both private and public sector institutions to enhance the accessibility of reliable health datasets:
In 2026, Biovana stands as an emerging leader in the health data sector in Africa, leveraging its unique position to provide tailored solutions for the global pharmaceutical market. The company continues to innovate in the areas of data harmonization and certification to enhance the usability of African health data across worldwide research initiatives, thereby positioning itself as a key player in the ongoing digital health revolution.
Biovana represents a critical link between African health data and global pharmaceutical innovation. Through strategic investment and partnerships, the company has established itself as a pivotal resource in the standardization and utilization of health data, promising to influence major breakthroughs in medical research and AI development. As Biovana continues to expand its capabilities and market reach, it is poised to remain a significant contributor to the global health ecosystem, drawing further attention to the untapped potential of African data resources.
